Next Article in Journal
Laboratory-Based SARS-CoV-2 Receptor Binding Domain Serologic Assays Perform with Equivalent Sensitivity and Specificity to Commercial FDA-EUA Approved Tests
Next Article in Special Issue
EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells
Previous Article in Journal
A Counterintuitive Neutrophil-Mediated Pattern in COVID-19 Patients Revealed through Transcriptomics Analysis
Previous Article in Special Issue
Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity
 
 
Article

Article Versions Notes

Viruses 2023, 15(1), 105; https://doi.org/10.3390/v15010105
Action Date Notes Link
article xml file uploaded 30 December 2022 08:52 CET Original file -
article xml uploaded. 30 December 2022 08:52 CET Update -
article pdf uploaded. 30 December 2022 08:52 CET Version of Record https://www.mdpi.com/1999-4915/15/1/105/pdf-vor
article html file updated 30 December 2022 08:54 CET Original file -
article xml file uploaded 5 January 2023 11:21 CET Update -
article xml uploaded. 5 January 2023 11:21 CET Update https://www.mdpi.com/1999-4915/15/1/105/xml
article pdf uploaded. 5 January 2023 11:21 CET Updated version of record https://www.mdpi.com/1999-4915/15/1/105/pdf
article html file updated 5 January 2023 11:23 CET Update -
article html file updated 1 March 2023 06:55 CET Update -
article html file updated 5 March 2023 01:47 CET Update https://www.mdpi.com/1999-4915/15/1/105/html
Back to TopTop